Norma Llansa

1.2k total citations
15 papers, 1.1k citations indexed

About

Norma Llansa is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Norma Llansa has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Cancer Research. Recurrent topics in Norma Llansa's work include Inflammatory mediators and NSAID effects (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Fibroblast Growth Factor Research (3 papers). Norma Llansa is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Fibroblast Growth Factor Research (3 papers). Norma Llansa collaborates with scholars based in United States, Australia and Spain. Norma Llansa's co-authors include Isaiah J. Fidler, Mordechai Gutman, R Sánchez, Rakesh K. Singh, C Bucana, David G. Menter, Scott M. Lippman, Anita L. Sabichi, Lawrence B. Lachman and Charles A. Dinarello and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Norma Llansa

15 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norma Llansa United States 13 534 285 265 262 160 15 1.1k
Ken‐ichi Kozaki Japan 21 906 1.7× 312 1.1× 134 0.5× 357 1.4× 209 1.3× 34 1.5k
Ben‐Kuen Chen Taiwan 22 566 1.1× 171 0.6× 264 1.0× 337 1.3× 90 0.6× 43 1.1k
Biserka Relić Belgium 15 594 1.1× 327 1.1× 170 0.6× 311 1.2× 210 1.3× 24 1.3k
Elias Gounaris United States 18 637 1.2× 411 1.4× 719 2.7× 148 0.6× 72 0.5× 27 1.5k
H Y Min United States 13 760 1.4× 251 0.9× 309 1.2× 421 1.6× 63 0.4× 14 1.7k
Shuji Kanayama Japan 18 496 0.9× 312 1.1× 109 0.4× 183 0.7× 94 0.6× 34 1.1k
Pazit Ben-Av Israel 10 447 0.8× 129 0.5× 97 0.4× 135 0.5× 316 2.0× 10 938
Elizabeth A. Saria United States 15 308 0.6× 284 1.0× 162 0.6× 171 0.7× 115 0.7× 27 810
Kirill V. Rosen Canada 19 875 1.6× 330 1.2× 130 0.5× 183 0.7× 48 0.3× 37 1.2k

Countries citing papers authored by Norma Llansa

Since Specialization
Citations

This map shows the geographic impact of Norma Llansa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Llansa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Llansa more than expected).

Fields of papers citing papers by Norma Llansa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norma Llansa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Llansa. The network helps show where Norma Llansa may publish in the future.

Co-authorship network of co-authors of Norma Llansa

This figure shows the co-authorship network connecting the top 25 collaborators of Norma Llansa. A scholar is included among the top collaborators of Norma Llansa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norma Llansa. Norma Llansa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yang, Peiying, David G. Menter, Carrie Cartwright, et al.. (2009). Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets. Molecular Cancer Therapeutics. 8(8). 2319–2328. 70 indexed citations
2.
Suraokar, Milind, Hung‐Yun Lin, Norma Llansa, et al.. (2008). High expression of epithelial-mesenchymal transition (EMT) markers in malignant mesothelioma and possible therapeutic intervention using an N-cadherin antagonist. Journal of Clinical Oncology. 26(15_suppl). 8067–8067. 1 indexed citations
3.
4.
Subbarayan, Vemparala, Jeri Kim, Peiying Yang, et al.. (2005). Inverse Relationship between 15-Lipoxygenase-2 and PPAR-γ Gene Expression in Normal Epithelia Compared with Tumor Epithelia. Neoplasia. 7(3). 280–293. 56 indexed citations
5.
Kim, Jeri, Peiying Yang, Milind Suraokar, et al.. (2005). Suppression of Prostate Tumor Cell Growth by Stromal Cell Prostaglandin D Synthase–Derived Products. Cancer Research. 65(14). 6189–6198. 68 indexed citations
6.
Sabichi, Anita L., Vemparala Subbarayan, Norma Llansa, Scott M. Lippman, & David G. Menter. (2004). Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.. PubMed. 13(11 Pt 1). 1704–9. 21 indexed citations
7.
Subbarayan, Vemparala, Anita L. Sabichi, Jeri Kim, et al.. (2004). Differential Peroxisome Proliferator-Activated Receptor-γ Isoform Expression and Agonist Effects in Normal and Malignant Prostate Cells. Cancer Epidemiology Biomarkers & Prevention. 13(11). 1710–1716. 32 indexed citations
8.
Sabichi, Anita L., Vemparala Subbarayan, Norma Llansa, Scott M. Lippman, & David G. Menter. (2004). Peroxisome Proliferator-Activated Receptor-γ Suppresses Cyclooxygenase-2 Expression in Human Prostate Cells. Cancer Epidemiology Biomarkers & Prevention. 13(11). 1704–1709. 20 indexed citations
9.
Subbarayan, Vemparala, Anita L. Sabichi, Norma Llansa, Scott M. Lippman, & David G. Menter. (2001). Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.. PubMed. 61(6). 2720–6. 103 indexed citations
10.
Singh, Rakesh Kumar, Mordechai Gutman, Norma Llansa, & Isaiah J. Fidler. (1996). Interferon-β Prevents the Upregulation of Interleukin-8 Expression in Human Melanoma Cells. Journal of Interferon & Cytokine Research. 16(8). 577–584. 49 indexed citations
11.
Singh, Rakesh K., C D Bucana, Norma Llansa, R Sánchez, & Isaiah J. Fidler. (1996). Cell density-dependent modulation of basic fibroblast growth factor expression by human interferon-beta. International Journal of Oncology. 8(4). 649–56. 12 indexed citations
12.
Singh, Rakesh K., Norma Llansa, Corazon D. Bucana, et al.. (1996). Cell density-dependent regulation of basic fibroblast growth factor expression in human renal cell carcinoma cells.. PubMed. 7(3). 397–404. 32 indexed citations
13.
Singh, Rakesh K., Mordechai Gutman, C Bucana, et al.. (1995). Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.. Proceedings of the National Academy of Sciences. 92(10). 4562–4566. 359 indexed citations
14.
Dong, Zhongyun, Xiulan Yang, Keping Xie, et al.. (1995). Activation of inducible nitric oxide synthase gene in murine macrophages requires protein phosphatases 1 and 2A activities. Journal of Leukocyte Biology. 58(6). 725–732. 37 indexed citations
15.
Lachman, Lawrence B., Charles A. Dinarello, Norma Llansa, & Isaiah J. Fidler. (1986). Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells.. The Journal of Immunology. 136(8). 3098–3102. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ken‐ichi Kozaki Breakdown of academic impact, for papers by Ben‐Kuen Chen Breakdown of academic impact, for papers by Biserka Relić Breakdown of academic impact, for papers by Elias Gounaris Breakdown of academic impact, for papers by H Y Min Breakdown of academic impact, for papers by Shuji Kanayama Breakdown of academic impact, for papers by Pazit Ben-Av Breakdown of academic impact, for papers by Elizabeth A. Saria Breakdown of academic impact, for papers by Kirill V. Rosen
Rankless by CCL
2026